The FDA on Friday approved Medtronic's Resolute Integrity drug-eluting stent, designed to treat coronary artery disease in patients with diabetes.
FDA approves stent to address CAD in diabetes patients
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||